期刊文献+

糖尿病肾病患者肾脏组织中C3aR、C5aR的表达 被引量:2

Expressions of C3aR,C5aR in kidney tissue from patients with diabetic nephropathy
在线阅读 下载PDF
导出
摘要 目的:探讨C3aR、C5aR在糖尿病肾病(DN)患者肾脏组织中的表达情况及其在DN发病中的作用。方法:选取DN患者的肾脏组织标本45例作为病例组,其中肾脏病理分级为Ⅰ+Ⅱ级13例、Ⅲ级21例、Ⅳ级11例;同时选取肾脏肿瘤患者手术切除的正常肾脏组织标本10例作为对照组。常规方法检测24 h尿蛋白定量、红细胞沉降率(ESR)、血肌酐(Scr)、血尿素氮(BUN)、C-反应蛋白(CRP)等指标。采用免疫组化方法检测C3aR、C5aR在各组肾脏组织中的表达。分析DN患者肾脏病理损伤级别与临床指标、肾组织中C3aR和C5aR阳性细胞百分比与临床指标的相关性。结果:C3aR和C5aR在各级DN患者肾脏组织中的表达均高于对照组,且随着DN肾脏病理损伤的加重,其表达逐渐增强(F=45.987,40.426,P均<0.001)。DN患者肾脏病理损伤级别与24 h尿蛋白定量、Scr、BUN、CRP等呈正相关(rS分别为0.529、0.595、0.516和0.425,P均<0.05);C3aR在肾脏组织中的阳性细胞百分比与24 h尿蛋白定量、Scr、BUN、CRP及ESR呈正相关(rS分别为0.342、0.613、0.489、0.315和0.321,P均<0.05)。C5aR在肾脏组织中的阳性细胞百分比也与以上指标呈正相关(rS分别为0.403、0.441、0.315、0.456和0.389,P均<0.05)。结论:C3aR、C5aR参与DN的发生与发展,在DN的病理损伤过程中起重要作用。 Aim:To detect the expressions of the receptors of C 3a and C5a(C3aR, C5aR) and investigate the poten-tial role of C3aR and C5aR in the pathogenesis of diabetic nephropathy (DN).Methods:A total of 45 cases of renal tissue from DN patients ( DN groups:13 cases at stageⅠ+Ⅱ,21 cases at stageⅢ, and 11 cases at stage Ⅳ) were selected ,and 10 cases of normal renal tissue from nephrectomy patients with kidney tumor were obtained as control group .The expres-sions of C3aR and C5aR in the above groups were detected respectively by immunohistochemistry .Some clinical test results such as:24 h urine protein,ESR,Scr,BUN,CRP etc.were measured by conventional methods .Results: The positive rates of C3aR and C5aR in DN groups were statistically significant higher than those in control group (F=45.987,40.426, respectively,all P〈0.001).In DN groups,positive correlations were found between some clinical test results (such as:24 h urine protein,Scr,BUN,CRP) and renal pathological stage (rS =0.529,0.595,0.516,0.425,respectively,all P 〈0.05);positive correlations were also found between clinical test results (such as:24 h urine protein,Scr,BUN,CRP, ESR)and the expression of C3aR in DN groups(rS =0.342,0.613,0.489,0.315,0.321,respectively,all P〈0.05),so&amp;nbsp;was the expression of C5aR in DN groups(rS =0.403,0.441,0.315,0.456,0.389,respectively,all P〈0.05).Conclu-sion:The high expressions of C3aR and C5aR may play an important role in the pathogenesis of DN .
出处 《郑州大学学报(医学版)》 CAS 北大核心 2014年第2期162-165,共4页 Journal of Zhengzhou University(Medical Sciences)
基金 国家自然科学基金资助项目81170668 河南省医学科技攻关计划基金资助项目201203042
关键词 糖尿病肾病 C3aR C5AR diabetic nephropathy C3 aR C5 aR
  • 相关文献

参考文献8

  • 1Yang WY, Lu JM, Weng JP, et al. Prevalence of diabetes a- mong men and women in China[J]. N Engl J Med,2010, 362(12) :1090.
  • 2杨维娜,王璇,蓝茜,李玥,任娟,何岚,吕社民,李冬民.2型糖尿病并发周围血管病变的临床流行病学分析[J].西安交通大学学报(医学版),2013,34(1):73-76. 被引量:70
  • 3Fan WX,Huang SM, Liu F, et al. Activation of the lectin complement pathway on human renal glomerular endothelial ceils triggered by high glucose and mannose-binding lectin [ J ]. African J Biotechno1,2011,80 ( 10 ) : 18539.
  • 4Tervaert TW, Mooyaart AL, Mnann K, et al. Pathologic classification of diabetic nephropathy[ J ]. J Am Soc Neph- rol,2010,21 (4) :556.
  • 5Li Q, Peng Q, Xing G, et al. Deficiency of C5aR prolongs renal allograft survival [ J ]. J Am Soc Nephrol, 2010,21 (8) :1344.
  • 6段喜梅,张颖,刘璐,周雅丽,权松霞,邢国兰.C3a、C5a及其受体在IgA肾病发病中的作用[J].郑州大学学报(医学版),2013,48(3):313-318. 被引量:10
  • 7Peng Q,Li K,Smyth LA,et al. C3a and C5a promate renal ischemia-reperfusion injury[ J ]. J Am Soc Nephrol, 2012, 23(9) :1474.
  • 8曹雪涛.医学免疫学[M].6版.北京:人民卫生出版社,2013:57.

二级参考文献31

  • 1黄丹丹,钟惠菊.2型糖尿病周围血管病变危险因素分析[J].临床内科杂志,2005,22(5):348-349. 被引量:6
  • 2杨伟,王立,万桂英.PAI-1与2型糖尿病动脉粥样硬化病变的研究[J].中国医师杂志,2005,7(9):1166-1168. 被引量:6
  • 3戈少红,应蓉,周营,蔡杏娟.炎症相关标志物与2型糖尿病大血管病变的关系研究[J].中国现代医药杂志,2007,9(3):23-25. 被引量:10
  • 4郭晓蕙 姚军.炎症与糖尿病[J].国外医学:内分泌学分册,2004,4(24):2-2.
  • 5KING H, AUBERT RE, HERMAN WH. Global burden of di- abetes, 1995-2025 Prevalence, numerical estimates, and pro- jections [J]. Diabetes Care, 1998, 21(9) :1414-1431.
  • 6SHAW JE, SICREE RA, ZIMMET PZ. Global estimates of the prevalence of diabetes for 2010 and 2030 [J]. Diabetes Res Clin Pract, 2010, 28, (1):4-14.
  • 7RAMACANDRAN A, MARC, SNEHALATHA C. Diabetes in Asia [J]. Lancet, 2010, 375(9712) :408-418.
  • 8DAVID S, CURTIS WB, PETER TB, et al. Position state- ment on the use of the ankle brachial index in the evaluation of patients with peripheral vascular disease [J]. J Vasc lnterv Ra- diol, 2002, 13(4) :353.
  • 9BUSE JB, GINSBERG HN, BAKRIS GL, et al. Primary pre- vention of cardiovascular diseases in people with diabetes melli- tus : a scientific statement from the American Heart Association and the American Diabetes Association [J]. Diabetes Care, 2007, 30(1) :162.
  • 10LENG GC, TAYLOR GS, LEE AJ, et al. Essential fatty acids and cardiovascular disease: the Edinburgh Artery Study [J]. Vasc Med, 1999, 4(4) :219-226.

共引文献85

同被引文献20

  • 1Rood IM, Deegens JK, Wetzels JF. Genetic causes of fo- cal segmental glomerulosclerosis: implications for clinical practice[ J]. Nephrol Dial Transplant, 2012,27 ( 3 ) :882.
  • 2Wei C, El Hindi S, Li J, et al. Circulating urokinase re- ceptor as a cause of focal segmenta! glomerulosclerosis [ J ]. Nat Med,2011,17(8) :952.
  • 3Markowitz GS, Schwimmer JA, Stokes MB, et al. Clq ne- phropathy: a variant of focal segmental glomeruloselerosis [ J ]. Kidney Int, 2003,64 ( 4 ) : 1232.
  • 4Turnberg D,Lewis M, Moss J, et al. Complement activation contributes to both glomerular and tubulointerstitial damage in adriamycin nephropathy in mice [ J ]. J Immunol, 2006, 177(6) :4094.
  • 5Bao L, Haas M, Pippin J, et al. Focal and segmental glo- merulosclerosis induced in mice lacking decay-accelerating factor in T cells [ J ]. J Clin Invest, 2009,119 ( 5 ) : 1264.
  • 6Morita Y,Ikeguchi H, Nakamura J, et al. Complement acti- vation products in the urine from proteinuric patients[ J]. J Am Soc Nephrol, 2000,11 ( 4 ) : 700.
  • 7Mizuno M, Blanchin S, Gasque P, et al. High levels of com- plement C3a receptor in the glomeruli in lupus nephritis [J]. Am J Kidney Dis,2007,49(5) :598.
  • 8Tang Z, Lu B, Hatch E, et al. C3a mediates epithelial-to- mesenchymal transition in proteinuric nephropathy [ J ]. J Am Soc Nephrol,2009,20(3):593.
  • 9Zheng Z, Schmidt-Ott KM, Chua S, et al. A Mendelian lo- cus on chromosome 16 determines susceptibility to doxoru- bicin nephropathy in the mouse[J]. Proc Natl Acad Sci U S A,2005,102(7) :2502.
  • 10Woo KT, Chart CM, Chin YM, et al. The changing pattern of primary glomerulonephritis in Singapore and other countries over the past 3 decades[J]. Clin Nephrol,2010,74(5) :372-383.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部